Abstract:Hyaluronic acid (HA) is a highly polymerized linear polysaccharide composed of d-glucuronic acid and N-acetylglucosamine. Hyaluronic acid of different molecular weights exhibits various functions. With the advancements of science and technology, low molecular weight HA has been increasingly employed in the medical field. For example, it can serve as a carrier for targeted anti-tumor drugs, production of wound dressings, and drug delivery systems, demonstrating a broad market prospect and a high application value. This paper comprehensively reviewed the research progress in low molecular weight HA in recent years, encompassing the preparation of low molecular weight HA by physical and chemical degradation methods and the mutation breeding of new strains for the production of low molecular weight HA. In addition, this paper discussed in depth the application of emerging strategies of synthetic biology in the production of low molecular weight HA, such as the modification of hyaluronan synthase and the regulation of substrate balance via manipulating the synthetic metabolic pathway. This paper aims to provide new ideas and methods for the efficient production of low molecular weight HA and point out the challenges to be addressed in the future research.